Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data| Exelixis, Inc. (NASDAQ: EXEL) | Delayed: 52.81 +1.47 (2.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.34 | 52 Week High | $17.00 | |||
| Open | $51.88 | 52 Week Low | $3.55 | |||
| Day High | $53.09 | P/E | N/A | |||
| Day Low | $51.70 | EPS | $-1.33 | |||
| Volume | 1,384,944 | |||||

